热门出版物 - 学术资源搜索

h5 指数:77
h5 中位数:117

h5 指数是指在过去整整 5 年中所发表文章的 h 指数。h 指在 2018-2022 年间发表的 h 篇文章每篇至少都被引用过 h 次的最大值。隐藏

出版物的 h5 中位数，是指出版物的 h5 指数所涵盖的所有文章获得的引用次数的中位值。隐藏

#4 Diabetes

标题/作者	引用次数	年份
Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) MJ Davies, DA D’Alessio, J Fradkin, WN Kernan, C Mathieu, G Mingrone, ... Diabetologia 61 (12), 2461-2498	1337	2018
Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes SE Inzucchi, RM Bergenstal, JB Buse, M Diamant, E Ferrannini, M Nauck, ... Diabetologia 58 (3), 429-442	649	2015
EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease European Association for the Study of the Liver, ... Diabetologia 59 (6), 1121-1140	635	2016
The mechanisms of action of metformin G Rena, DG Hardie, ER Pearson Diabetologia 60 (9), 1577-1585	465	2017
Pathophysiology of diabetic dyslipidaemia: where are we? B Vergès Diabetologia 58 (5), 886-899	297	2015
Glucose concentrations of less than 3.0 mmol/l (54 mg/dl) should be reported in clinical trials: a joint position statement of the American Diabetes Association and the Europian Association for the Study of Diabetes International Hypoglycaemia Study Group Diabetologia 60 (1), 3-6	296	2017
Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial P Gæde, J Oellgaard, B Carstensen, P Rossing, H Lund-Andersen, ... Diabetologia 59 (11), 2298-2307	280	2016
Metformin and the gastrointestinal tract LJ McCreight, CJ Bailey, ER Pearson Diabetologia 59 (3), 426-435	268	2016
Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6 year follow-up study of the METSIM cohort H Cederberg, A Stančáková, N Yaluri, S Modi, J Kuusisto, M Laakso Diabetologia 58 (5), 1109-1117	259	2015
Adipose tissue macrophages: going off track during obesity L Boutens, R Stienstra Diabetologia 59 (5), 879-894	255	2016
Epigenetic mechanisms in diabetic complications and metabolic memory MA Reddy, E Zhang, R Natarajan Diabetologia 58 (3), 443-455	244	2015
GLUT2, glucose sensing and glucose homeostasis B Thorens Diabetologia 58 (2), 221-232	239	2015
Targeting renal glucose reabsorption to treat hyperglycaemia: the pleiotropic effects of SGLT2 inhibition V Vallon, SC Thomson Diabetologia 60 (2), 215-225	222	2017
The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study JP Krischer, KF Lynch, DA Schatz, J Ilonen, Å Lernmark, WA Hagopian, ... Diabetologia 58 (5), 980-987	217	2015
Empagliflozin decreases myocardial cytoplasmic Na+ through inhibition of the cardiac Na+/H+ exchanger in rats and rabbits A Baartscheer, CA Schumacher, RCI Wüst, JWT Fiolet, GJM Stienen, ... Diabetologia 60 (3), 568-573	205	2017
SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? N Sattar, J McLaren, SL Kristensen, D Preiss, JJ McMurray Diabetologia 59 (7), 1333-1339	203	2016
Metformin: historical overview CJ Bailey Diabetologia 60 (9), 1566-1576	195	2017
Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark P Damm, A Houshmand-Oeregaard, L Kelstrup, J Lauenborg, ... Diabetologia 59 (7), 1396-1399	182	2016
Adipose tissue plasticity: how fat depots respond differently to pathophysiological cues V Pellegrinelli, S Carobbio, A Vidal-Puig Diabetologia 59 (6), 1075-1088	171	2016
SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review S Verma, JJV McMurray Diabetologia 61 (10), 2108-2117	168	2018

1 - 20

计算机程序会自动估算并确定日期和引用次数。